Beta-blockers in the treatment of hypertension

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F25%3A10001372" target="_blank" >RIV/00064190:_____/25:10001372 - isvavai.cz</a>

Result on the web

<a href="https://doi.org/10.33678/cor.2025.047" target="_blank" >https://doi.org/10.33678/cor.2025.047</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.33678/cor.2025.047" target="_blank" >10.33678/cor.2025.047</a>

Result language

angličtina

Original language name

Beta-blockers in the treatment of hypertension

Original language description

Beta-blockers are currently among the five major classes of antihypertensive drugs with a proven reduction in cardiovascular (CV) morbidity and mortality. The latest recommendations of the European Society of Hypertension (ESH) have reassessed their position in the treatment of hypertension and have included them among the drugs of the first choice in the treatment of hypertension. Prevention of cardiovascular (CV) complications in hypertension has been documented by large clinical trials for atenolol, metoprolol, oxprenolol, and propranolol. Beta-blockers are widely used in the management of hypertension accompanied by comorbidities such as chronic coronary syndrome, post-myocardial infarction, arrhythmias, angina pectoris, heart failure with reduced or preserved ejection fraction, acute coronary syndrome, atrial fibrillation, as well as in women of reproductive age or planning pregnancy and in the treatment of hypertension in pregnancy. Administration of beta-blockers is particularly indicated in hypertensive patients with a resting heart rate &gt; 80/min. The beneficial effects of beta-blockers have been demonstrated in more than fifty clinical conditions, some of which are outside the field of CV disease. Beta-blockers may also be used in pregnancy: labetalol is considered a drug of choice for treatment of hypertension in pregnancy, while metoprolol is safe in a later phase of pregnancy being also compatible with breastfeeding.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2025

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

COR ET VASA

ISSN

0010-8650

e-ISSN

1803-7712

Volume of the periodical

67

Issue of the periodical within the volume

Supplement 2

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

8

Pages from-to

18-25

UT code for WoS article

001537852900004

EID of the result in the Scopus database

2-s2.0-105005842966